1. Home
  2. VMD vs IRWD Comparison

VMD vs IRWD Comparison

Compare VMD & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Viemed Healthcare Inc.

VMD

Viemed Healthcare Inc.

HOLD

Current Price

$7.26

Market Cap

280.4M

Sector

N/A

ML Signal

HOLD

Logo Ironwood Pharmaceuticals Inc.

IRWD

Ironwood Pharmaceuticals Inc.

HOLD

Current Price

$3.55

Market Cap

251.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VMD
IRWD
Founded
2006
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.4M
251.8M
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
VMD
IRWD
Price
$7.26
$3.55
Analyst Decision
Buy
Analyst Count
0
5
Target Price
N/A
$5.34
AVG Volume (30 Days)
146.8K
2.3M
Earning Date
11-05-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
35.92
N/A
EPS
0.34
0.18
Revenue
$254,794,000.00
$338,987,000.00
Revenue This Year
$20.05
N/A
Revenue Next Year
$17.44
$4.01
P/E Ratio
$21.26
$20.22
Revenue Growth
18.89
N/A
52 Week Low
$5.93
$0.53
52 Week High
$8.93
$5.13

Technical Indicators

Market Signals
Indicator
VMD
IRWD
Relative Strength Index (RSI) 64.67 61.03
Support Level $6.60 $3.50
Resistance Level $7.44 $3.80
Average True Range (ATR) 0.20 0.32
MACD 0.07 -0.05
Stochastic Oscillator 75.60 55.49

Price Performance

Historical Comparison
VMD
IRWD

About VMD Viemed Healthcare Inc.

Viemed Healthcare Inc is a provider of medical equipment and home therapy to patients with respiratory disease, oxygen problems, sleep apnea and PAP treatment. The company also provides services such as respiratory disease management, neuromuscular care, in-home sleep testing and sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company generates majority its revenue from medical equipment rental, sales and supply.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: